Harvest Integrated Research Organization (HiRO), a boutique global CRO, is pleased to announce the signing of a Memorandum of Understanding (MOU) with Hallym University Sacred Heart Hospital in Seoul, South Korea. This strategic alliance aims to drive innovation in drug research and development while strengthening collaboration across the medical and research sectors.
The collaboration outlines shared objectives focused on fostering innovation in health and health technology, accelerating drug research and development, and enhancing the efficiency of clinical trials, all while upholding the highest standards of quality and care. By uniting efforts, HiRO and Hallym University Sacred Heart Hospital are well-positioned to make significant progress in improving healthcare outcomes and addressing unmet clinical needs for patients in South Korea and beyond.
Hallym University Sacred Heart Hospital, equipped with cutting-edge facilities and a highly skilled team of medical professionals, specializes in various therapeutic areas and is fully capable of conducting clinical trials ranging from early to late stages in accordance with ICH-GCP guidelines. In turn, HiRO will leverage its extensive global experience and strong presence in the US, Europe, and Asia-Pacific regions to optimize clinical research efficiency, and proactively introduce multiregional trials to South Korea and the hospital.
